Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q3:25 Results
Newsfile·2025-12-02 03:35
          Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $$9.00 Price Target Following Q3:25 ResultsDecember 01, 2025 2:35 PM EST | Source: Emerging Growth ResearchNew York, New York--(Newsfile Corp. - December 1, 2025) - Emerging Growth Research today announced the release of its Q3:25 quarterly update on SBC Medical Group Holdings, Inc. (NASDAQ: SBC), reiterating a Buy-Extended rating and maintaining its 12-month price target of $$9.00, representing sign ...